文献速递前列腺癌

机器人辅助MRI-超声融合经会阴靶向前列腺活检

Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy.
PubMed 文献 · Urology · 2021-06-26

该研究展示了机器人辅助磁共振成像-超声融合经会阴前列腺活检的关键步骤,对疑似前列腺癌男性行多参数MRI并PI-RADS评分,在全身麻醉下融合实时经直肠超声与MRI模型进行靶向和系统活检。433例患者中临床显著前列腺癌检出率为46%,PI-RADS 5、4、3分别为85%、38%、16%(P < .001),总体并发症率13%,以Clavien-Dindo I级为主(99%)。

要点

  • 机器人辅助经会阴靶向活检临床显著前列腺癌检出率46%,PI-RADS 5达85%。
  • 总体并发症率13%,多为Clavien-Dindo I级,常见尿潴留10%和需膀胱冲洗的明显肉眼血尿2%。
  • 前列腺体积每增加10 mL,尿潴留风险增加(OR 1.4,95% CI 1.21-1.65,P < .001)。

核心结论

  • 机器人辅助经会阴前列腺活检是可靠、准确且并发症少的前列腺癌检测方法。

研究设计与样本

  • 对疑似前列腺癌男性行3-Tesla多参数MRI并PI-RADS v2评分,由放射科医生标记前列腺轮廓和可疑病灶生成三维MRI模型。
  • 所有活检在全身麻醉下进行,创建实时经直肠超声模型并与MRI模型非刚性软件融合,在立体定向引导下用机器人辅助平台行经会阴靶向和系统活检。
  • 共433例患者接受靶向和系统活检。

主要发现

  • 临床显著前列腺癌(Grade group ≥2)检出率为46%。
  • PI-RADS 5、4、3的临床显著前列腺癌检出率分别为85%、38%、16%(P < .001)。
  • 总体并发症率为13%,其中99%为Clavien-Dindo I级。
  • 最常见并发症为尿潴留(10%)和需膀胱冲洗的明显肉眼血尿(2%)。
  • 前列腺体积每增加10 mL,尿潴留风险增加(OR 1.4,95% CI 1.21-1.65,P < .001);仅报告1例轻度尿路感染。

临床怎么用

  • 可用于疑似前列腺癌男性的靶向和系统活检,尤其适用于PI-RADS评分较高者。
  • 术前应评估前列腺体积以预判尿潴留风险,术后需关注排尿情况和血尿。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To demonstrate the key steps to perform robot-assisted magnetic resonance imaging-ultrasound fusion transperineal prostate biopsy. MATERIALS AND METHODS: Men with suspicion of prostate cancer underwent 3-Tesla multi-parametric MRI and were assigned a Prostate Imaging Reporting and Data System v2 score (PI-RADS). The prostate outline and suspicious lesions were marked by our radiologist using our software to produce a 3-dimensional prostate MRI model. All biopsies were performed under general anaesthesia and the real-time transrectal ultrasound model is created and subsequently fused with the MRI model using non-rigid software fusion. Transperineal targeted and systematic biopsy were then performed under stereotactic guidance using our robot-assisted prostate biopsy platform. Our clinically significant prostate cancer (Grade group ≥2) detection rates were previously described.1 RESULTS: Out of the 433 patients who underwent targeted and systematic biopsy, clinically-significant cancer detection rate was 46% (85% for PI- RADS 5 vs 38% for PI-RADS 4 vs 16% for PI-RADS 3; P < .001). Our overall complication rate was 13%, out of which the majority were Clavien-Dindo I (99%). The most common complications encountered were urinary retention (10%) and significant gross hematuria requiring bladder irrigation (2%). A higher prostate volume was associated with greater odds of urinary retention (OR 1.4, 95% CI: 1.21-1.65, P < .001 for every 10 mL increase in prostate volume). There was only 1 reported case of mild urinary tract infection. CONCLUSION: Robot-assisted transperineal prostate biopsy has established itself as a reliable and accurate method of prostate cancer detection with minimal morbidity.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Lee AY, Chen K, Law YM, et al. Robot-assisted Magnetic Resonance Imaging-ultrasound Fusion Transperineal Targeted Biopsy. Urology. 2021. PMID: 34186128. doi:10.1016/j.urology.2021.06.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。